Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

Clinical trial NCT07696481 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07696481
Sponsor: Zhujiang Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Acute Leukemia Relapsed or Refractory Acute Lymphoblastic Leukemia Relapsed or Refractory Acute Myeloid Leukemia (AML)

Start date: 2026-08-01
Primary completion: 2029-05-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.